The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / October / Stress Testing Exposes Glaucoma Risk
Glaucoma Health Economics and Policy News

Stress Testing Exposes Glaucoma Risk

Water-drinking stress test may identify glaucoma eyes at risk of progression even when routine office IOP appears well controlled

10/7/2026 3 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary
Objective:

To assess whether the water-drinking test (WDT) predicts functional and structural glaucoma progression beyond routine office intraocular pressure (IOP) measurements.

Approach:
  • Study design: Prospective study of 67 eyes from 36 participants with glaucoma, followed for an average of 2.2 years and about 14 testing visits per eye.
  • Stress test and outcomes: Participants drank one liter of water within five minutes. IOP was measured before drinking and at 15, 30, and 45 minutes; visual field mean deviation and retinal nerve fiber layer thickness were tracked over time.
Key Findings:
  • Mean office IOP was 14.8 mmHg, while mean WDT peak IOP was 20.6 mmHg.
  • Eyes with WDT peaks above 21 mmHg had faster visual field mean deviation loss and retinal nerve fiber layer thinning than eyes at or below that threshold.
  • Of 59 eyes with office IOP within severity-specific targets, 22 (37%) exceeded 21 mmHg during WDT and subsequently showed faster progression than apparently controlled eyes below the threshold.
  • Among 13 rapid progressors, 3 were above target by routine office measurements, whereas 10 had WDT peaks above 21 mmHg.
Interpretation:

The authors propose that WDT may act as a composite stress test of the eye’s ability to maintain IOP homeostasis, revealing pressure responses not apparent from resting office measurements.

Limitations:
  • The cohort was modest in size.
  • Average follow-up was just over two years.
  • Treatment changes were not controlled.
  • The findings require confirmation in larger, multicenter populations.
Conclusion:

The study suggests that WDT peak IOP may identify progression risk in some eyes whose office IOP appears controlled; the findings are exploratory.

Sources:
  • Article context provided

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: